Target research on tumor biology characteristics of mir-155-5p regulation on gastric cancer cell

被引:0
|
作者
Feng, Jun-an [1 ]
机构
[1] Peoples Hosp Zhengzhou, Dept Gastroenterol, Zhengzhou, Henan, Peoples R China
关键词
mir-155-5p; expression profile chip; target gene; gastric cancer cells; protein expression; CA IX; EXPRESSION; CARCINOMA; PATHWAY; IDENTIFICATION; STRATEGIES; CXCR4; AXIS;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
After the mir-155-5p over expressed in gastric cancer cells, the expression profile chip was adopted to screen its target genes. Some of the intersection of target genes were selected based on the bioinformatics prediction, in order to study the mechanism of its function and role of research. Affymetrix eukaryotic gene expression spectrum was conducted to screen mir-155-5p regulated genetic experiment. Western blot technique was employed to detect and screen the protein expression of target genes. Mimics was transfected in BGC-823 of gastric cancer cells. Compared with mimics-nc group and mock group, the mRNA expression quantities of SMAD1, STAT1, CAB39, CXCR4 and CA9 were significantly lower. After the gastric cancer cells BGC-823 and MKN-45 had been transfected by mimics, compared with mimics-nc (MNC) group and mock (MOCK) group, it was decreased for the protein expression of SMAD1, STAT1 and CAB39 in mimics (MIMICS) group. the verification of qRT-PCR demonstrated that SMAD1, STAT1, CAB39, CXCR4 and CA9 were the predicted target genes and target proteins of mir-155-5p, the over expression of mir-155-5p could enable the decreasing of its expression level in gastric cancer cells MKN-45 and BGC-823.
引用
收藏
页码:711 / 718
页数:8
相关论文
共 50 条
  • [1] Target research on tumor biology characteristics of mir-155-5p regulation on gastric cancer cell
    Ma, Ning
    Feng, Jun-An
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (07): : 12553 - 12562
  • [2] The tumor suppressor role of miR-155-5p in gastric cancer
    Li, Shiqing
    Zhang, Tao
    Zhou, Xiaoqing
    Du, Zonghan
    Chen, Fumin
    Luo, Jun
    Liu, Qingsong
    ONCOLOGY LETTERS, 2018, 16 (02) : 2709 - 2714
  • [3] Resveratrol Downregulates miR-155-5p to Block the Malignant Behavior of Gastric Cancer Cells
    Su, Nana
    Li, Lanlan
    Zhou, Erle
    Li, Hong
    Wu, Shuhua
    Cao, Zhang
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [4] Resveratrol Downregulates miR-155-5p to Block the Malignant Behavior of Gastric Cancer Cells
    Su, Nana
    Li, Lanlan
    Zhou, Erle
    Li, Hong
    Wu, Shuhua
    Cao, Zhang
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [5] Resveratrol Downregulates miR-155-5p to Block the Malignant Behavior of Gastric Cancer Cells
    Su, Nana
    Li, Lanlan
    Zhou, Erle
    Li, Hong
    Wu, Shuhua
    Cao, Zhang
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [6] miR-155-5p Facilitates the Growth of Lobaplatin-Treated Gastric Cancer Cells
    Gao, Yuewen
    Wang, Yanqin
    Meng, Lingxin
    Wang, Kai
    Liu, Xiaoyong
    Chen, Lei
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (03): : 1325 - 1334
  • [7] Inhibition of miR-155-5p in non-small cell lung cancer, a potential target for induction of autophagy
    Moayedi, Fatemeh
    Shojaei-Ghahrizjani, Fereshteh
    Yaghoobi, Hajar
    META GENE, 2021, 28
  • [8] The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis
    Li, Hailong
    Xie, Shoupin
    Liu, Min
    Chen, Zhaofeng
    Liu, Xiaojun
    Wang, Li
    Li, Dayan
    Zhou, Yongning
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (01) : 197 - 208
  • [9] The miR-155-5p/FBXO11 axis inhibits the progression of gastric cancer via the mTOR pathway
    Yuan, Tao
    Liu, Haiyan
    Li, Fangfang
    Meng, Qingyue
    Wang, Yajuan
    Yuan, Mei
    TRANSLATIONAL CANCER RESEARCH, 2025, 14 (02) : 1375 - 1387
  • [10] miR-155-5p and miR-1246 as promising biomarkers in oral squamous cell carcinomas
    Ramamoorthy, Maheswari
    Guru, Sameer A.
    Koner, Bhidhan C.
    Kumar, Priya
    Urs, Aadithya B.
    ANNALS OF ONCOLOGY, 2022, 33 : S498 - S499